|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61P 25/18 | (2006.01) |
| (11) | Number of the document | 3830092 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19876025.8 |
| Date of filing the European patent application | 2019-08-02 | |
| (97) | Date of publication of the European application | 2021-06-09 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-03 |
| (46) | Date of publication of the claims translation | 2023-09-11 |
| (86) | Number | PCT/US2019/044814 |
| Date | 2019-08-02 |
| (87) | Number | WO 2020/086136 |
| Date | 2020-04-30 |
| (30) | Number | Date | Country code |
| 201862714100 P | 2018-08-03 | US |
| (72) |
VOLKMANN, Robert, A. , US
ANDERSON, David, R. , US
MALEKIANI, Sam , US
PISER, Timothy , US
KEANEY, Gregg, F. , US
LEISER, Steven, C. , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Heteroaromatiniai NMDA receptorių moduliatoriai ir jų panaudojimai |
| HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2023-07-19 | 5 | 115.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-08-02 |